Diverse Biotech is Drug Discovery in United States that focus on targeted medicines business. Founded in 2017. They cover business area such as operator, a focus, novel therapeutic, advanced conjugate chemistry, cannabidiol, CBD, target medicine, novel new chemical entity, drug, new standard, care, cancer patient, -treat, pancreatic cancer, glioblastoma/brain cancer, new cannabinoid therapy.
2017
( 7 years old in 2024 )
Targeted Medicines
-
PA Biotechnology Center
3805 Old Easton Road - Suite 111
Doylestown, PA 18902
United States
Private
operatora focusnovel therapeuticadvanced conjugate chemistrycannabidiolCBDtarget medicinenovel new chemical entitydrugnew standardcarecancer patient-treatpancreatic cancerglioblastoma/brain cancernew cannabinoid therapy
* We use standard office opening hours in near Diverse Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Diverse Biotech is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Diverse Biotech business is focusing on Targeted Medicines.
Diverse Biotech headquarter office and corporate office address is located in PA Biotechnology Center 3805 Old Easton Road - Suite 111 Doylestown, PA 18902 United States.
Diverse Biotech was founded in United States.
In 2024, Diverse Biotech is currently focus on targeted medicines sector.
Above is snippet of Google Trends for "targeted medicines" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Diverse Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
